Evaluation of the functional properties of short-chain xylooligosaccharides obtained from the enzymatic hydrolysis of bamboo culm
Bioactive Carbohydrates and Dietary Fibre · 2024-12 · 32 · 100431
DOI: 10.1016/j.bcdf.2024.100431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioactive Carbohydrates and Dietary Fibre, 2024-12. Verfasst von Marcos Fellipe da Silva und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Silva, M. F. D., Sganzerla, W. G., Ávila, P. F., Carneiro, T. F., Clerici, M. T. P. S., & Goldbeck, R. (2024). Evaluation of the functional properties of short-chain xylooligosaccharides obtained from the enzymatic hydrolysis of bamboo culm. Bioactive Carbohydrates and Dietary Fibre, 32, 100431. https://doi.org/10.1016/j.bcdf.2024.100431
Vancouver
Silva MFD, Sganzerla WG, Ávila PF, Carneiro TF, Clerici MTPS, Goldbeck R. Evaluation of the functional properties of short-chain xylooligosaccharides obtained from the enzymatic hydrolysis of bamboo culm. Bioactive Carbohydrates and Dietary Fibre. 2024;32:100431. doi:10.1016/j.bcdf.2024.100431
BibTeX
@article{Silva2024,
author = {Silva, Marcos Fellipe da and Sganzerla, William Gustavo and Ávila, Patrícia Félix and Carneiro, Tânia Forster and Clerici, Maria Teresa Pedrosa Silva and Goldbeck, Rosana},
title = {Evaluation of the functional properties of short-chain xylooligosaccharides obtained from the enzymatic hydrolysis of bamboo culm},
journal = {Bioactive Carbohydrates and Dietary Fibre},
year = {2024},
volume = {32},
pages = {100431},
doi = {10.1016/j.bcdf.2024.100431}
}
EUVIMED